Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sandostatin and the Belfast experience.

K D Buchanan1, J S Collins, A Varghese

  • 1Institute of Clinical Science, Queen's University, Belfast, UK.

Digestion
|January 1, 1990
PubMed
Summary

Sandostatin (octreotide) effectively treated apudomas, particularly vipomas and carcinoids, improving symptoms like diarrhea and flushing. However, it was ineffective for insulinoma and Zollinger-Ellison syndrome, with response decreasing in larger tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular characterization of <i>Bertiella studeri</i> infecting a primate in South India.

Helminthologia·2024
Same author

Effectiveness of Preparedness Training Delivered to Pre-final and Final Year Nursing Undergraduates to Combat COVID-19: A Need-based Initiative.

Mymensingh medical journal : MMJ·2023
Same author

Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.

Vaccine·2022
Same author

Ultrasound imaging for the differential diagnosis of periapical lesions of endodontic origin in comparison with histopathology - a systematic review and meta-analysis.

International endodontic journal·2020
Same author

Effect of preoperative oral administration of steroids in comparison to an anti-inflammatory drug on postoperative pain following single-visit root canal treatment - a double-blind, randomized clinical trial.

International endodontic journal·2020
Same author

Development of a surgical assessment tool for national policy monitoring & evaluation in Ethiopia: A quality improvement study.

International journal of surgery (London, England)·2020

Area of Science:

  • Endocrinology
  • Medical Oncology
  • Gastroenterology

Background:

  • Apudomas are rare neuroendocrine tumors with diverse clinical presentations.
  • Sandostatin (octreotide) is a somatostatin analog used to manage symptoms of certain neuroendocrine tumors.

Purpose of the Study:

  • To evaluate the efficacy and side effects of Sandostatin (octreotide) in patients with apudomas.
  • To determine which subtypes of apudomas respond best to Sandostatin treatment.

Main Methods:

  • A retrospective study of 24 patients with 26 apudomas treated with Sandostatin (octreotide).
  • Clinical and biochemical responses were assessed for different apudoma subtypes.

Main Results:

  • Excellent clinical and biochemical response observed in 2 patients with vipoma.

Related Experiment Videos

  • Sandostatin improved diarrhea (70%), flushing (58%), and wheezing (100%) in 15 patients with carcinoids.
  • No response to Sandostatin was noted in patients with insulinoma and Zollinger-Ellison syndrome. Response declined with increased tumor size and markers. Side effects were minimal.

    • Conclusions:

    • Sandostatin (octreotide) is a beneficial treatment for vipomas and carcinoids, offering significant symptom relief.
    • Treatment with Sandostatin is not effective for insulinoma or Zollinger-Ellison syndrome.
    • Tumor burden and markers may predict Sandostatin response in apudoma patients.